Known targets — ChEMBL curated mechanism
The experimentally established mechanism targets of Chlorpromazine. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | DRD2 known ✓ | P14416 | 5/20 | 0.95 |
| ▸ | DRD3 known ✓ | P35462 | 5/20 | 0.95 |
| ▸ | DRD4 known ✓ | P21917 | 3/20 | 0.95 |
| ▸ | HTR2A known ✓ | P28223 | 3/20 | 0.95 |
| ▸ | CYP1A2 | P05177 | 9/20 | 0.95 |
| ▸ | CYP2D6 | P10635 | 9/20 | 0.95 |
| ▸ | HTR1A | P08908 | 6/20 | 0.95 |
| ▸ | LMNA | P02545 | 6/20 | 0.95 |
| ▸ | CYP2C19 | P33261 | 5/20 | 0.95 |
| ▸ | MAPT | P10636 | 5/20 | 0.95 |
| ▸ | TP53 | P04637 | 5/20 | 0.95 |
| ▸ | CHRM2 | P08172 | 5/20 | 0.95 |
| ▸ | ADRA2A | P08913 | 5/20 | 0.95 |
| ▸ | CHRM1 | P11229 | 5/20 | 0.95 |
| ▸ | DRD1 | P21728 | 5/20 | 0.95 |
| ▸ | SLC6A2 | P23975 | 5/20 | 0.95 |
| ▸ | SLC6A4 | P31645 | 5/20 | 0.95 |
| ▸ | ADRA1A | P35348 | 5/20 | 0.95 |
| ▸ | OPRM1 | P35372 | 5/20 | 0.95 |
| ▸ | KCNH2 | Q12809 | 5/20 | 0.95 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Chlorpromazine SCHEMBL29367385 | 0.97 | CYP1A2 (1.00) | CYP1A2CYP2D6HTR1ALMNACYP2C19 | |
| Chlorpromazine SCHEMBL8321 | 0.97 | CYP1A2 (1.00) | CYP1A2CYP2D6HTR1ALMNACYP2C19 | |
| Chlorpromazine SCHEMBL29358018 | 0.97 | CYP1A2 (1.00) | CYP1A2CYP2D6HTR1ALMNACYP2C19 | |
| Chlorpromazine SCHEMBL8503036 | 0.96 | CYP1A2 (1.00) | CYP1A2CYP2D6HTR1ALMNACYP2C19 | |
| Chlorpromazine SCHEMBL29714121 | 0.96 | CYP1A2 (1.00) | CYP1A2CYP2D6HTR1ALMNACYP2C19 | |
| Chlorpromazine SCHEMBL23326209 | 0.96 | CYP1A2 (1.00) | CYP1A2CYP2D6HTR1ALMNACYP2C19 | |
| Chlorpromazine SCHEMBL27607834 | 0.96 | CYP1A2 (0.97) | CYP1A2CYP2D6HTR1ALMNACYP2C19 | |
| Chlorpromazine SCHEMBL5483904 | 0.96 | CYP1A2 (1.00) | CYP1A2CYP2D6HTR1ALMNACYP2C19 | |
| Chlorpromazine SCHEMBL41771 | 0.96 | CYP1A2 (1.00) | CYP1A2CYP2D6HTR1ALMNACYP2C19 | |
| Chlorpromazine SCHEMBL29351728 | 0.96 | CYP1A2 (1.00) | CYP1A2CYP2D6HTR1ALMNACYP2C19 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Appears in 3990 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3194027-B1 | COMPOSITIONS FOR USE IN TREATING PSYCHOTIC DISORDERS | SOUND PHARMACEUTICALS INCORPORATED (US) | 2026-02-11 | — | — | EP | claimed |
| EP-3060043-B1 | PESTICIDAL COMPOSITIONS AND RELATED METHODS | CORTEVA AGRISCIENCE LLC (US) | 2025-11-26 | — | — | EP | claimed |
| EP-3578542-B1 | COMPOSITIONS HAVING PESTICIDAL UTILITY AND PROCESSES RELATED THERETO | CORTEVA AGRISCIENCE LLC (US) | 2025-11-12 | — | — | EP | claimed |
| US-20250319073-A1 | COMPOSITIONS AND METHODS FOR THE TREATMENT OF HUNTINGTON’S DISEASE AND HTT PROTEINOPATHIES | STEALTH BIOTHERAPEUTICS INC. (US) | 2025-10-16 | — | — | US | claimed |
| EP-3578543-B1 | COMPOSITIONS COMPRISING MOLECULES HAVING PESTICIDAL UTILITY AND PROCESSES RELATED THERETO | CORTEVA AGRISCIENCE LLC (US) | 2025-08-20 | — | — | EP | claimed |
| EP-3578541-B1 | COMPOSITIONS COMPRISING MOLECULES HAVING PESTICIDAL UTILITY, AND PROCESSES RELATED THERETO | CORTEVA AGRISCIENCE LLC (US) | 2025-05-28 | — | — | EP | claimed |
| WO-2025078446-A1 | MICROFLUIDIC DEVICE AND METHOD THEREOF FOR RAPID ASSAYS IN SAMPLES | OLSSON CARL (SE) | 2025-04-17 | — | — | WO | claimed |
| EP-4525840-A1 | COMPOSITIONS AND METHODS FOR THE TREATMENT OF HUNTINGTON'S DISEASE AND HTT PROTEINOPATHIES | Stealth BioTherapeutics Inc. (US) | 2025-03-26 | — | — | EP | claimed |
| US-20250032503-A1 | USE OF APREPITANT FOR TREATING ALZHEIMER'S DISEASE | HOTH THERAPEUTICS, INC. | 2025-01-30 | — | — | US | claimed |
| US-12004868-B2 | Liposomal mitigation of drug-induced inhibition of the cardiac IKr channel | SIGNPATH PHARMA INC. (US) | 2024-06-11 | — | — | US | claimed |
| US-20020172712-A1 | Antiemetic, anti-motion sustained release drug delivery system | GLYCOBIOSCIENCES INC. (CA) | 2002-11-21 | — | — | US | claimed |
| EP-1212000-A4 | METHOD OF CONTROLLING BODY TEMPERATURE WHILE REDUCING SHIVERING | RADIANT MEDICAL INC (US) | 2002-10-25 | — | — | EP | claimed |
| EP-1212000-A1 | SYSTEM FOR CONTROLLING BODY TEMPERATURE WHILE REDUCING SHIVERING | Radiant Medical, Inc. (US) | 2002-06-12 | — | — | EP | claimed |
| WO-2001058469-A1 | METHODS FOR TREATING GLAUCOMA | WAX MARTIN B (US) | 2001-08-16 | — | — | WO | claimed |
| US-6231594-B1 | Method of controlling body temperature while reducing shivering | RADIANT MEDICAL, INC. | 2001-05-15 | — | — | US | claimed |
| WO-2001010323-A1 | METHOD OF CONTROLLING BODY TEMPERATURE WHILE REDUCING SHIVERING | RADIANT MEDICAL, INC. (US) | 2001-02-15 | — | — | WO | claimed |
| EP-1005651-A1 | METHODS OF IDENTIFYING BIOLOGICAL AGENT COMPOSITIONS | SUPRATEK PHARMA, INC. (CA) | 2000-06-07 | — | — | EP | claimed |
| WO-1998042723-A9 | METHODS AND COMPOSITIONS FOR THE DIAGNOSIS AND TREATMENT OF NEUROPSYCHIATRIC DISORDERS | — | 1999-03-04 | — | — | WO | claimed |
| WO-1999008112-A1 | METHODS OF IDENTIFYING BIOLOGICAL AGENT COMPOSITIONS | SUPRATEK PHARMA INC. (CA) | 1999-02-18 | — | — | WO | claimed |
| CN-1130513-A | Medicine for treating self-biting disease for fox and preparing process thereof | ZHAO JIHE (CN) | 1996-09-11 | — | — | CN | claimed |